Cancer site | Employment years in SAS | Women | Men | ||||||
---|---|---|---|---|---|---|---|---|---|
O* | E† | SIR‡ | 95% CI | O* | E† | SIR‡ | 95% CI | ||
*Observed number of cases. | |||||||||
†Expected number of cases, taking age and calendar period into consideration. | |||||||||
‡SIR, standardised incidence ratio. | |||||||||
All cancer | <10 | 35 | 31.48 | 1.11 | 0.74 to 1.48 | 9 | 6.66 | 1.35 | 0.62 to 2.56 |
10–19 | 24 | 29.91 | 0.80 | 0.48 to 1.12 | 7 | 6.91 | 1.01 | 0.41 to 2.09 | |
20 | 14 | 12.19 | 1.15 | 0.63 to 1.93 | 16 | 13.51 | 1.18 | 0.68 to 1.92 | |
Breast cancer | <10 | 13 | 9.56 | 1.36 | 0.72 to 2.32 | – | – | – | – |
10–19 | 13 | 10.32 | 1.26 | 0.67 to 2.15 | – | – | – | – | |
20 | 7 | 5.04 | 1.39 | 0.56 to 2.86 | – | – | – | – | |
Malignant melanoma | <10 | 6 | 2.45 | 2.45 | 0.90 to 5.33 | 2 | 0.48 | 4.15 | 0.50 to 14.98 |
10–19 | 2 | 1.86 | 1.08 | 0.13 to 3.89 | 3 | 0.46 | 6.59 | 1.36 to 19.25 | |
20 | 3 | 0.65 | 4.60 | 0.95 to 13.44 | 1 | 0.63 | 1.59 | 0.04 to 8.86 |